InflaRx N.V. (Nasdaq: NASDAQ:IFRX), a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today topline results from the... InflaRx N.V ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Spotify Technology S.A. 1.37% $70.6B ...

José Ignacio González Quinzaños I think the course was definitely more intensive than I ever thought it would be, it’s an incredibly comprehensive course, and it’s fantastic that we even go into ...